# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001731122-24-000732
Filing Date
2024-05-06
Accepted
2024-05-06 06:03:33
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEFA14A | e5643_defa14a.htm | DEFA14A | 10078
2 | GRAPHIC | img_001.jpg | GRAPHIC | 1309523
3 | GRAPHIC | img_002.jpg | GRAPHIC | 751823
| Complete submission text file | 0001731122-24-000732.txt |  | 2846519

Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 980608404 | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-37606 | Film No.: 24915396
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)